Recommendations for prevention and control of influenza in children, 2014-2015

Carrie L. Byington, Elizabeth D. Barnett, Herbert Dele Davies, Kathryn M. Edwards, Mary Anne Jackson, Yvonne A. Maldonado, Dennis L. Murray, Mobeen H. Rathore, Mark H. Sawyer, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2014-2015 season include the following: 1. The influenza vaccine composition for the 2014-2015 season is unchanged from the 2013-2014 season. 2. Both trivalent and quadrivalent influenza vaccines are available in the United States for the 2014-2015 season. 3. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 4. Live attenuated influenza vaccine (LAIV) should be considered for healthy children 2 through 8 years of age who have no contraindications or precautions to the intranasal vaccine. If LAIV is not readily available, inactivated influenza vaccine (IIV) should be used; vaccination should not be delayed to obtain LAIV. 5. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age reflects that virus strains in the vaccine have not changed from last season. As always, pediatricians, nurses, and all other health care personnel should be immunized themselves and should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify clinical influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)e1503-e1519
JournalPediatrics
Volume134
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

Influenza Vaccines
Human Influenza
Attenuated Vaccines
Vaccines
Antiviral Agents
Immunization
Influenza
Inactivated Vaccines
Vaccine
Infection Control
Health Personnel
Vaccination
Nurses
Pediatrics
Viruses
Morbidity
Delivery of Health Care
Mortality
Therapeutics

Keywords

  • Children
  • Immunization
  • Inactivated influenza vaccine
  • Influenza
  • Live attenuated influenza vaccine
  • Pediatrics
  • Vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Byington, C. L., Barnett, E. D., Davies, H. D., Edwards, K. M., Jackson, M. A., Maldonado, Y. A., ... Zaoutis, T. E. (2014). Recommendations for prevention and control of influenza in children, 2014-2015. Pediatrics, 134(5), e1503-e1519. https://doi.org/10.1542/peds.2014-2413

Recommendations for prevention and control of influenza in children, 2014-2015. / Byington, Carrie L.; Barnett, Elizabeth D.; Davies, Herbert Dele; Edwards, Kathryn M.; Jackson, Mary Anne; Maldonado, Yvonne A.; Murray, Dennis L.; Rathore, Mobeen H.; Sawyer, Mark H.; Schutze, Gordon E.; Willoughby, Rodney E.; Zaoutis, Theoklis E.

In: Pediatrics, Vol. 134, No. 5, 01.11.2014, p. e1503-e1519.

Research output: Contribution to journalReview article

Byington, CL, Barnett, ED, Davies, HD, Edwards, KM, Jackson, MA, Maldonado, YA, Murray, DL, Rathore, MH, Sawyer, MH, Schutze, GE, Willoughby, RE & Zaoutis, TE 2014, 'Recommendations for prevention and control of influenza in children, 2014-2015', Pediatrics, vol. 134, no. 5, pp. e1503-e1519. https://doi.org/10.1542/peds.2014-2413
Byington CL, Barnett ED, Davies HD, Edwards KM, Jackson MA, Maldonado YA et al. Recommendations for prevention and control of influenza in children, 2014-2015. Pediatrics. 2014 Nov 1;134(5):e1503-e1519. https://doi.org/10.1542/peds.2014-2413
Byington, Carrie L. ; Barnett, Elizabeth D. ; Davies, Herbert Dele ; Edwards, Kathryn M. ; Jackson, Mary Anne ; Maldonado, Yvonne A. ; Murray, Dennis L. ; Rathore, Mobeen H. ; Sawyer, Mark H. ; Schutze, Gordon E. ; Willoughby, Rodney E. ; Zaoutis, Theoklis E. / Recommendations for prevention and control of influenza in children, 2014-2015. In: Pediatrics. 2014 ; Vol. 134, No. 5. pp. e1503-e1519.
@article{7bca4a21a7c044819ad76bd019e406d6,
title = "Recommendations for prevention and control of influenza in children, 2014-2015",
abstract = "The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2014-2015 season include the following: 1. The influenza vaccine composition for the 2014-2015 season is unchanged from the 2013-2014 season. 2. Both trivalent and quadrivalent influenza vaccines are available in the United States for the 2014-2015 season. 3. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 4. Live attenuated influenza vaccine (LAIV) should be considered for healthy children 2 through 8 years of age who have no contraindications or precautions to the intranasal vaccine. If LAIV is not readily available, inactivated influenza vaccine (IIV) should be used; vaccination should not be delayed to obtain LAIV. 5. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age reflects that virus strains in the vaccine have not changed from last season. As always, pediatricians, nurses, and all other health care personnel should be immunized themselves and should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify clinical influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.",
keywords = "Children, Immunization, Inactivated influenza vaccine, Influenza, Live attenuated influenza vaccine, Pediatrics, Vaccine",
author = "Byington, {Carrie L.} and Barnett, {Elizabeth D.} and Davies, {Herbert Dele} and Edwards, {Kathryn M.} and Jackson, {Mary Anne} and Maldonado, {Yvonne A.} and Murray, {Dennis L.} and Rathore, {Mobeen H.} and Sawyer, {Mark H.} and Schutze, {Gordon E.} and Willoughby, {Rodney E.} and Zaoutis, {Theoklis E.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1542/peds.2014-2413",
language = "English (US)",
volume = "134",
pages = "e1503--e1519",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "5",

}

TY - JOUR

T1 - Recommendations for prevention and control of influenza in children, 2014-2015

AU - Byington, Carrie L.

AU - Barnett, Elizabeth D.

AU - Davies, Herbert Dele

AU - Edwards, Kathryn M.

AU - Jackson, Mary Anne

AU - Maldonado, Yvonne A.

AU - Murray, Dennis L.

AU - Rathore, Mobeen H.

AU - Sawyer, Mark H.

AU - Schutze, Gordon E.

AU - Willoughby, Rodney E.

AU - Zaoutis, Theoklis E.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2014-2015 season include the following: 1. The influenza vaccine composition for the 2014-2015 season is unchanged from the 2013-2014 season. 2. Both trivalent and quadrivalent influenza vaccines are available in the United States for the 2014-2015 season. 3. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 4. Live attenuated influenza vaccine (LAIV) should be considered for healthy children 2 through 8 years of age who have no contraindications or precautions to the intranasal vaccine. If LAIV is not readily available, inactivated influenza vaccine (IIV) should be used; vaccination should not be delayed to obtain LAIV. 5. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age reflects that virus strains in the vaccine have not changed from last season. As always, pediatricians, nurses, and all other health care personnel should be immunized themselves and should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify clinical influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

AB - The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The American Academy of Pediatrics recommends annual seasonal influenza immunization for all people 6 months and older, including all children and adolescents. Highlights for the upcoming 2014-2015 season include the following: 1. The influenza vaccine composition for the 2014-2015 season is unchanged from the 2013-2014 season. 2. Both trivalent and quadrivalent influenza vaccines are available in the United States for the 2014-2015 season. 3. Annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference). 4. Live attenuated influenza vaccine (LAIV) should be considered for healthy children 2 through 8 years of age who have no contraindications or precautions to the intranasal vaccine. If LAIV is not readily available, inactivated influenza vaccine (IIV) should be used; vaccination should not be delayed to obtain LAIV. 5. The dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age reflects that virus strains in the vaccine have not changed from last season. As always, pediatricians, nurses, and all other health care personnel should be immunized themselves and should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify clinical influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

KW - Children

KW - Immunization

KW - Inactivated influenza vaccine

KW - Influenza

KW - Live attenuated influenza vaccine

KW - Pediatrics

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84908866519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908866519&partnerID=8YFLogxK

U2 - 10.1542/peds.2014-2413

DO - 10.1542/peds.2014-2413

M3 - Review article

C2 - 25246619

AN - SCOPUS:84908866519

VL - 134

SP - e1503-e1519

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

ER -